The 2014 top 50 Pharma company list is out, with an interesting number of movers and shakers
By Alamelu Elango
- Johnson and Johnson retains its lead at the top of the list for another year
- Four of the top 10 pharmaceutical companies report revenue losses
- A number of companies were acquired therefore leave the list
- Valeant pharmaceuticals reports highest % revenue increase
Here at Current Partnering, we have compiled the 2014 top 50 pharma company list based on revenues from 2013. The article looks at the top 50 companies overall and discusses the top ten companies in detail. The big movers and shakers of the year are also highlighted and predictions for 2014 are made.
The remaining part of this article is Premium content – see below for access options.
Purchase this article
$35.00 BUY NOW
For $35.00, purchase this 5,756-word article and receive immediate online access.
100% Satisfaction Guarantee.
Report: Merger and Acquisition Report
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity
Current Partnering provides industry executives with partnering best practice and essential business intelligence. Further details about the range of reports and subscription services offered can be found at our website:
This article was published July 2014.
For inquiries about the content of this article, please contact: